CalTIC secures seed financing to develop a new class of drugs | Max-Planck-Gesellschaft https://www.mpg.de/19297831/caltic-secures-seed-financing-to-develop-a-new-class-of-drugs
The KHAN Technology Transfer Fund I (KHAN-I) has committed up to EUR 3 million in milestone dependent payments to CalTIC, a Dortmund based start-up, for the discovery of a new class of drugs.
has placed great confidence in CalTIC,” says Klaus Dinkel